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ABSTRACT
The porphyrias are rare inherited meta-
bolic disorders of the heme biosynthesis 
pathway. Acute intermittent porphyria is 
the most common form that may result 
in acute porphyric crises with abdominal 
pain, vomiting, hemodynamic distur-
bances, autonomic dysfunction, pyrexia 
and neurological deterioration. Provoca-
tive factors include hormonal fluctuations, 
fasting, dehydration, smoking, excessive 
alcohol or illegal drugs intake and stress 
from illness or surgery. However, the most 
frequent triggers are cytochrome P450-in-
ducing drugs, especially in relation to an-
aesthesia. We report a case of a 63-year-old 
female with acute intermittent porphyria 
and severe hemodynamic instability dur-
ing and after liver resection taken for hepa-
tocellular carcinoma. The procedure was 
predominantly characterized by unusual 
hemodynamic instability with refractory 
hypertension, despite adequate analgesia 
and depth of anaesthesia. Several differ-
ent treatments failed to reduce high blood 
pressure. There is a possibility that some 
drugs used in the perioperative period 
caused acute porphyric crises, which was 
manifested by severe hemodynamic insta-
bility. Autonomic neuropathy might have 
caused labile blood pressure as well. A pre-
cise etiology of hemodynamic instability 
in the presented case is difficult to assess, 
since other provocative factors like fasting, 
dehydration and stress from surgery were 
also present. A careful anaesthetic plan 
and treatment and postoperative surveil-
lance in the ICU are cornerstones in the 
management of patients with porphyria 
subjected to major surgical procedures. 
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INTRODUCTION
The porphyrias are rare inherited meta-
bolic disorders of the heme biosynthesis 
pathway. They are classified according to 
the deficient enzyme, the hepatic or eryth-
ropoietic site of porphyrin production and 
the possibility of an acute attack. (1, 2) 
Only three autosomal dominant acute he-
patic forms (acute intermittent porphyria 
(AIP), variegate porphyria and hereditary 
coproporphyria) may result in acute por-
phyric crises (APC). The most common is 
AIP with an overall prevalence in Europe 
of approximately 1 per 20,000. (3, 4) The 
diagnosis of severe recurrent acute por-
phyria is associated with an increased risk 
of hepatocellular carcinoma (HCC). (5) 
Various factors may provoke APC, includ-
ing physiological hormonal fluctuations, 
fasting, dehydration, smoking, excessive 
alcohol or illegal drugs intake and stress 
from illness or surgery. (4) However, the 
most frequent triggers are cytochrome 
P450-inducing drugs, especially in relation 
to anaesthesia. (6) According to James and 
Hift, drugs can be categorized as definitely 
unsafe to use, probably safe, and contro-
versial. For many drugs there are no avail-
able data (3, 4) (table 1). The symptoms of 
APC include severe abdominal pain, vom-
iting, constipation, acute psychiatric and 
neurologic manifestations, tachycardia, 
hypertension, tremors, excessive sweating, 
urinary retention, cardiac arrhythmias, 
electrolyte disturbances and acute respira-
tory paralysis. Perioperative hypovolemia 
is common, as well as autonomic neuropa-
thy, which may cause labile blood pressure. 
(3) Inconsistent clinical signs and suscep-
tibility to precipitating factors, even in the 
same patient, are common and cannot be 
overemphasized. (7, 8)
CASE REPORT 
We report a case of a 63-year-old female 
with a diagnosis of porphyria and an unu-
sual hemodynamic instability during and 
after liver resection taken for HCC. She 
was diagnosed with AIP in her student 
days but has not had any acute attack of the 
illness for the last 10 years. Periodically, ab-
dominal pain attributable to AIP manifest-
ed. In addition to porphyria, hypothyreosis 
treated with levothyroxine, arterial hyper-
tension treated with angiotensin II antago-
nist and diuretic were recorded. After the 
HCC was diagnosed and declared as inop-
erable, she was treated twice by palliative 
procedures (transarterial chemoemboliza-
tion) in another institution. In our hospital 
decided decision was made that radical 
liver resection could be undertaken. A 
preoperative evaluation showed normal 
biochemical and haematological tests and 
no acute distress on the physical exam. The 
patient was premedicated with diazepam, 
pantoprazole and levothyroxine. In the 
operating room the list of porphyria safe 
and unsafe drugs was prepared and placed 
at a noticeable place (table 1). The induc-
tion of general anaesthesia with sufentanil, 
propofol and vecuronium was uneventful. 
Central venous, arterial and urinary cath-
eters and a nasogastric tube were inserted. 
For the maintenance of anaesthesia, sevo-
SIGNA VITAE 2015; 10(SUPPL 1): 63-65
64   |  SIGNA VITAE
flurane combined with oxygen and nitrous 
oxide (N2O) was used. Successive boluses 
of sufentanil and vecuronium were ad-
ministered on a regular basis. The patient’s 
heart rate and blood pressure were contin-
uously and invasively monitored. The en-
tire surgical procedure was characterized 
by unusual hemodynamic instability, pre-
dominantly with refractory hypertension, 
despite adequate analgesia and depth of 
anaesthesia. Alternating, short periods of 
profound hypotension were present as well 
(figure 1). Several different treatments, in-
cluding generous boluses of sufentanil and 
vecuronium, short inhalation boluses of 
8% sevoflurane, the addition of N2O and 
boluses of urapidil, propranolol and mag-
nesium sulfate failed to reduce blood pres-
sure. Finally, nitroglycerin was introduced 
continuously. Two units of red blood cells 
(RBCs) were administered because of in-
traoperative blood losses. After the pro-
cedure, the patient was admitted to the 
ICU, where a nitroglycerin infusion was 
continued throughout the next two days. 
Moxonidine and doxazosin were added 
to her usual peroral antihypertensive 
therapy. She was treated with intravenous 
glucose and dismissed from the ICU after 
four days. The second procedure was per-
formed 14 days after the first one, with a 
similar perioperative management. Again, 
hemodynamic instability was pronounced, 
with a hypertensive crisis and tachycardia 
at the beginning and the end of the pro-
cedure (figure 1). The hypertensive crisis 
was treated with intravenous propranolol 
and urapidil. The patient was dismissed 
the next day from the ICU and seven days 
later from the hospital. 
DISCUSSION
Perioperative management of a porphyric 
patient is inevitably a challenge, consider-
ing that many agents and conditions may 
induce cytochromes and trigger APC. The 
porphyrinogenic potential of anaesthetic 
agents in our patient was difficult to as-
sess with precision, since other provoking 
factors such as fasting, dehydration and 
stress from the surgery where also present. 
(4) During the anaesthesia and in the ICU 
definitely unsafe drugs were not used. We 
used drugs that are considered probably 
safe and drugs whose safety is controver-
sial or not known. There is a possibility 
that some of them caused APC, which was 
manifested by pronounced hemodynamic 
instability. Blood pressure oscillations 
caused by APC or autonomic neuropathy 
could be the most distinctive symptoms in 
the perioperative period. (3) Apart from 
AIP, the cause of hemodynamic instabil-
ity in our patient could have been unregu-
lated essential hypertension. The patient’s 
medical history, doses of antihypertensives 
used before the procedure and preopera-
tive evaluation do not indicate this as a 
primary cause. It cannot be excluded that 
hypertension and tachycardia might have 
been caused by the painful stimuli due to 
the extensive procedure. However, this is 
less likely since analgesia and the depth of 
anaesthesia were maintained at the upper 
limits. Despite the fact that the liver resec-
tion was extensive and prolonged, only 
two doses of RBCs were applied because of 
intraoperative blood losses. In the case of 
severe bleeding, it is possible that hemody-
namic disturbance would have been even 
greater, which might have aggravated APC 
or caused long-term neurologic compli-
cations, hypertension and chronic renal 
failure. (6, 8, 9) Considering that renal fail-
ure is a quite common complication after 
major surgery, it is extremely important 
to monitor renal function in the porphy-
ric patients. Intravenous administration of 
glucose was initiated since it is known that 
increased carbohydrates intake may ame-
liorate APC. (7, 9) 
Figure 1. Hemodynamic instability during 
the first procedure (upper row) and at the 
beginning and the end of the second pro-
cedure (lower row)
CONCLUSION
 Any clinical disorder in the perioperative 
period displayed by an identified porphy-
ric patient should be considered as the on-
set of APC. (6) A careful anaesthetic plan, 
treatment and postoperative surveillance 
in the ICU are cornerstones in the man-
agement of patients with porphyria sub-
jected to major surgical procedures. A de-
tailed preoperative evaluation, early APC 
diagnosis, drugs selection in the operat-
ing theatre and ICU, avoidance of fasting, 
dehydration, hypovolemia, infection and 
reduction of surgical stress could prevent 
acute attacks and long-term complications 
associated with porphyria. 
Table 1. List of porphyria safe and unsafe drugs (adapted from Allman KG, Wilson IH. Oxford handbook of anaesthesia 3rd ed. New 
York: Oxford University Press;2011.
Definitely unsafe Probably safe Controversial
Induction agents Barbiturates, Etomidate Propofol Ketamine
Inhalational agents Enflurane Nitrous oxide, Isoflurane, Sevoflurane




Neuromuscular reversing agents Atropine, Glycopyrronium,
Neostigmine
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Analgesics Pentazocine Alfentanil, Aspirin, Buprenorfine, 




Local anesthetics Mepivacaine, Ropivacaine Bupivacaine, Prilocaine, Procaina-
mide, Procaine
Cocaine, Lidocaine
Sedatives Chlordiazepoxide, Nitrazepam Lorazepam, Midazolam, Temaz-
epam, Chlorpromazine
Diazepam
Antiemetics and H2 antagonists Cimetidine, Metoclopramide Droperidol, Phenotiazines Ondansetron, Ranitidine
CVS drugs Hydralazine, Nifedipine, Phenoxy-
benzamine





Others Aminophylline, Oral contraceptive 
pill, Phenytoin, Sulphonamides
Steroids
CVS – cardiovascular system
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